Filing Details

Accession Number:
0001209191-21-033399
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 11:35:11
Reporting Period:
2021-05-17
Accepted Time:
2021-05-18 11:35:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1668243 Urogen Pharma Ltd. URGN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821479 Drew Jason Smith C/o Urogen Pharma Ltd.
400 Alexander Park Drive
Princeton NJ 08540
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-17 2,500 $15.71 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.